IGF1 and hyperinsulinism: They can lead to the development of metabolic abnormalities, such as insulin resistance, hyperinsulinemia, increased levels of Insulin-like Growth Factor-1 (IGF-1), an increase of the concentration of steroid and peptide hormones and an increase of the activity of pro-inflammatory cytokines.